Vistagen (VTGN) Reports Positive Signals for Fasedienol in Very Severe SAD

Vistagen reported exploratory analyses showing statistically significant SUDS improvements with fasedienol vs placebo in very severe social anxiety disorder subgroups, including in a repeat-dose Phase 2a study and a post-hoc PALISADE-4 Phase 3 subgroup.Material DetailsContext by AI AnalystThis is a…